James J. Burns & Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.4M Hold
3,672
– – 0.48% 35
2026
Q1
$3.38M Buy
3,672
+1,615
+79% +$1.64M 0.46% 41
2025
Q4
$2.21M Sell
2,057
-50
-2% -$47.8K 0.31% 48
2025
Q3
$1.61M Sell
2,107
-7
-0.3% -$5.21K 0.24% 50
2025
Q2
$1.65M Buy
2,114
+5
+0.2% +$3.88K 0.27% 48
2025
Q1
$1.74M Buy
2,109
+2
+0.1% +$1.66K 0.31% 47
2024
Q4
$1.63M Buy
2,107
+100
+5% +$82.8K 0.28% 50
2024
Q3
$1.78M Hold
2,007
– – 0.32% 47
2024
Q2
$1.82M Buy
2,007
+7
+0.4% +$5.6K 0.36% 44
2024
Q1
$1.53M Hold
2,000
– – 0.53% 31
2023
Q4
$1.17M Buy
+2,000
New +$1.17M 0.28% 51

Other funds holding LLY

James J. Burns & Company's LLY Position: Q2 2026 in Review

James J. Burns & Company held its Eli Lilly (LLY) position steady in Q2 2026 at 3,672 shares worth $4.4M. The position accounts for 0.48% of the portfolio, ranked #35.

James J. Burns & Company first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • James J. Burns & Company held 3,672 shares of Eli Lilly worth $4.4M as of Q2 2026.
  • James J. Burns & Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.48% of James J. Burns & Company's portfolio in Q2 2026, its #35 holding.
  • James J. Burns & Company first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on James J. Burns & Company's 13F filing for Q2 2026, filed 6 Aug 2026.